Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
J Colloid Interface Sci ; 420: 101-11, 2014 Apr 15.
Article in English | MEDLINE | ID: mdl-24559707

ABSTRACT

The aim of the current work was to study the physico-chemical interactions of a bisphosphonate molecule, risedronate, with a well-characterised synthetic nanocrystalline apatite (NCA) as a model bone mineral. We adopted a global approach, using complementary physico-chemical techniques such as FTIR, RAMAN and NMR spectroscopies in order to learn more about the interaction process of risedronate with the apatitic surface. The results obtained suggest that risedronate adsorption corresponds to an ion substitution reaction with phosphate ions occurring at the crystal surface. This mechanism explains the greater amount adsorbed (N) for NCA, compared to well crystallised stoichiometric hydroxyapatite, attributable to the well-developed hydrated layer at the surface of the nanocrystals. However, most calcium ions remain attached to the solid phase and the formation of insoluble risedronate calcium salts must also be considered as a competitive reaction to the adsorption. Thus a calcium risedronate salt was synthesised and fully characterised for comparison to the solids after adsorption. Following spectroscopic results, it can be concluded that a strong interaction was established between risedronate ions and calcium ions at the apatitic surface. However, under these experimental conditions there is no nucleation of a distinct calcium risedronate salt and the apatite crystals retain their integrity.


Subject(s)
Apatites/chemistry , Etidronic Acid/analogs & derivatives , Nanoparticles/chemistry , Etidronic Acid/chemistry , Magnetic Resonance Spectroscopy , Risedronic Acid , Spectrum Analysis, Raman
2.
J Biomed Mater Res B Appl Biomater ; 91(1): 46-54, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19365821

ABSTRACT

The composition and evolution of a brushite-type calcium phosphate cement was investigated by Solid-State NMR and X-ray during the setting process. The cement is obtained by mixing beta-tricalcium phosphate [Ca(3)(PO(4))(2), beta-TCP] and monocalcium phosphate monohydrate [Ca(H(2)PO(4))(2).H(2)O, MCPM] in presence of water, with formation of dicalcium phosphate dihydrate or brushite [CaHPO(2).2H(2)O, DCPD]. Analysis of the initial beta-TCP paste has shown the presence of beta-calcium pyrophosphate [Ca(2)P(2)O(7), beta-CPy] and that of the initial MCPM a mixture of MCPM and dicalcium phosphate [CaHPO(4), DCP]. Follow-up of the chemical composition by (31)P Solid-State NMR enables to show that the chemical setting process appeared to reach an end after 20 min. The constant composition observed at the end of the process was similarly determined.


Subject(s)
Biocompatible Materials/chemistry , Bone Cements/chemistry , Calcium Phosphates/chemistry , Magnetic Resonance Spectroscopy/methods , Chemical Phenomena , Materials Testing , Water/chemistry , X-Ray Diffraction
3.
J Colloid Interface Sci ; 302(1): 214-29, 2006 Oct 01.
Article in English | MEDLINE | ID: mdl-16857208

ABSTRACT

We explored and compared several synthetic methods of grafting silica with strong (alkyltriphenylphosphonium, tetralkylammonium, propylpyridinium and dialkylimidazolium) and weak (gamma-aminopropyl, gamma-(N-imidazolyl)propyl) anion-exchanging groups starting with commercially available chloroalkyl- and gamma-aminopropylsilanes. Structure of the intermediate and final materials was investigated by elemental analysis, titration, 13C, 29Si, 31P MAS NMR, DRIFT, and TPD MS. The derivatives of alkyltriphenylphosphonium, propylpyridinium and dialkylimidazolium cation can be prepared with satisfactory quaternisation yields (ca. 30-100%) via the nucleophilic substitution of gamma-chloropropyl groups either in the silane or in chloropropylsilica, resulting in bonded phases with moderate densities: 0.2-1.0 group nm(-2) (onium salts) and 0.2-1.5 group nm(-2) (amines). Parallel one-pot end-capping/hydrophobization can be done if a mixture of target silane with end-capping reagent or gamma-chloropropylsilane is used. The grafted layer is highly stable at the level of Si-C bonds and decomposes at ca. 400 degrees C, while the onium functions begin to decompose at ca. 250 degrees C, lowering the thermal stability of materials. Thus, anion-exchanging silicas can be envisaged for the use as catalyst supports at moderate temperatures.


Subject(s)
Onium Compounds/chemistry , Silicon Dioxide/chemistry , Silicon Dioxide/chemical synthesis , Temperature , Catalysis , Molecular Structure , Surface Properties
4.
J Phys Chem B ; 109(29): 13948-56, 2005 Jul 28.
Article in English | MEDLINE | ID: mdl-16852750

ABSTRACT

Mesoporous molecular sieves Si-MCM-41 (purely siliceous) and Ti-MCM-41 (partly covered with a surface layer of TiO2) were functionalized with phosphate groups by treatment with POCl3 (denoted -MCM-41(P)and Ti-MCM-41(P), respectively). With the use of TEM, X-ray diffraction, and N2 adsorption, it was shown that the initial hexagonal structure, the high specific surface area, and porosity are retained in the functionalized materials but are not as good as in the starting materials. 1H MAS NMR and 31P MAS NMR revealed that the surface of Si-MCM-41(P) consists of silicon phosphate and pyrophosphate species. That of Ti-MCM-41(P) additionally contains titanium dihydro-, hydro-, and pyrophosphate species, the latter being predominant. TPD of adsorbed ammonia for Si-MCM-41(P) and Ti-MCM-41(P) showed that functionalization leads to the creation of moderate and strong acid sites. A combination of mesoporous structure with acidic properties makes the MCM-41 functionalized with phosphate groups promising for use as solid acid catalysts.

5.
Bone ; 26(4): 341-8, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10719276

ABSTRACT

Bisphosphonates, potent inhibitors of bone resorption, have been used clinically to correct the continued loss of bone mass in osteoporosis and in other conditions. However, there has been some concern that long-term treatment with these compounds, as well as more recently developed drugs, may also decrease the rate of bone formation. Bisphosphonates, which are strongly bound to hydroxyapatite crystals, may alter the structure and reactivity of the crystals, interfere with new crystal nucleation and growth, as well as alter the short-range order of newly formed crystals. We have investigated the chemistry and structure of the solid calcium-phosphate mineral phase of lumbar vertebrae of ovariectomized, 6.5-month-old rats treated with bisphosphonates for 1 year after onset of osteopenia. Appropriate control groups were used for comparison. The techniques used to assess the mineral phase were chemical analyses, Fourier transform-infrared (FT-IR) and FT-Raman spectroscopy, FT-IR microspectroscopy, and phosphorus-31 magic-angle-sample spinning nuclear magnetic resonance spectroscopy ((31)P MAS NMR). The (31)P MAS NMR spectra of trabecular bone of lumbar vertebrae of control, ovariectomized, and treated animals were similar. However, there were several significant differences in the results obtained by FT-IR spectroscopy of the whole tissue samples, FT-IR microspectroscopy of sections of bone, and chemical analyses. For example, whereas chemical analyses demonstrated that the CO(3) content of the mineral phase of the ovariectomized animals was decreased compared with controls, FT-IR microspectroscopy of bone sections showed no changes in the relative CO(3) content, but some changes in the environment of the CO(3) groups. However, chemical analyses of the crystals, combined with data from all three spectroscopic methods and with data from serum analysis, did indicate small changes in the mineral phase after ovariectomy, corrected after treatment with bisphosphonates. In any event, the chemical and structural data in the present studies demonstrate that the bisphosphonate, tiludronate, does not significantly alter the mineral components of bone after 1 year of treatment during the course of which bone loss was reversed.


Subject(s)
Bone Diseases, Metabolic/physiopathology , Diphosphonates/pharmacology , Lumbar Vertebrae/drug effects , Ovariectomy , Animals , Apatites/analysis , Bone Diseases, Metabolic/chemically induced , Bone Diseases, Metabolic/drug therapy , Bone Resorption/chemically induced , Bone Resorption/drug therapy , Bone Resorption/physiopathology , Calcium/blood , Cholecalciferol/blood , Disease Models, Animal , Female , Lumbar Vertebrae/physiology , Magnetic Resonance Spectroscopy , Parathyroid Hormone/blood , Phosphorus/blood , Phosphorus Radioisotopes , Rats , Rats, Sprague-Dawley , Spectroscopy, Fourier Transform Infrared , Weight Loss
6.
Bone ; 25(2 Suppl): 103S-105S, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10458287

ABSTRACT

Calcium phosphate bone replacement biomaterials are widely used in different applications. Structure, composition, and organization are, before implantation, analyzed with different methods. Among them, X-ray diffraction is a recognized test. As bioresorption produces more amorphous material, the process is observed and quantified via scanning electron microscopy. Comparatively high-resolution 31P solid-state nuclear magnetic resonance spectroscopy is able to analyze raw ceramics composition and to estimate osteoformation.


Subject(s)
Bone Substitutes/chemistry , Calcium Phosphates/chemistry , Magnetic Resonance Spectroscopy , Animals , Bone Development/drug effects , Bone Substitutes/pharmacology , Calcium Phosphates/pharmacology , Ceramics/chemistry , Femur/diagnostic imaging , Femur/drug effects , Human Growth Hormone/pharmacology , Microscopy, Electron, Scanning , Osseointegration/drug effects , Phosphorus Isotopes , Porosity , Powders , Rabbits , Radiography , Recombinant Proteins/pharmacology
7.
Biopolymers ; 33(11): 1715-23, 1993 Nov.
Article in English | MEDLINE | ID: mdl-8241429

ABSTRACT

Two crystals d(C2GCG2) and d(C5GCG5) have been studied under microscope by Fourier transform ir spectroscopy and Raman spectroscopy. The x-ray diffraction study of the latter crystal had shown that the d(C5GCG5) sequence is the first DNA dodecamer known to adopt a canonical A conformation [N. Verdaguer, J. Aymami, D. Fernandez-Forner, I. Fita, M. Coll, T. Huynh-Dinh, J. Igolen, and J. A. Subirana (1991) Journal of Molecular Biology, Vol. 221, pp. 623-635]. Characteristic ir marker bands and Raman marker peaks of the A conformation have thus been obtained and are compared with previously proposed assignments correlated to fiber diffraction x-ray results obtained on polymers. The d(C2GCG2) sequence crystal had previously been studied in an intermediate form between B and Z [L. Urpi, J. P. Ridoux, J. Liquier, N. Verdagner, I. Fita, J. A. Subirana, F. Iglesias, T. Huynh-Dinh, J. Igolen, and E. Taillandier (1989) Nucleic Acids Research, Vol. 17, pp. 6669-6679]. In this paper we present results obtained from a crystal with this oligonucleotide in Z conformation. The effect of the crystallization conditions on the geometry of the obtained oligomer helix is discussed. The influence of the addition, to the central tetramer CGCG, of dCn stretches (at the 5' end) and dGn stretches (at the 3' end) of different lengths, on the conformational flexibility of the nucleic acid, is considered.


Subject(s)
Oligonucleotides/chemistry , Base Sequence , Chemical Phenomena , Chemistry, Physical , Molecular Sequence Data , Nucleic Acid Conformation , Spectroscopy, Fourier Transform Infrared , Spectrum Analysis, Raman
SELECTION OF CITATIONS
SEARCH DETAIL
...